Latest article
U.S. FDA declines to approve Provention Bio’s diabetes drug
(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
Welsh health enterprise AFLUENCR in multi-million greenback Kiwi acquisition
Welsh fitness company AFLUENCR, led by founder and CEO Gareth Manger, today announced a multi-million dollar (NZ) acquisition by New Zealand-based MacroActive, the transactional...
Else Diet to Take part within the Lytham Companions Winter
VANCOUVER, British Columbia, December 07, 2021 (GLOBE NEWSWIRE) - ELSE NUTRITION HOLDINGS INC. (TSX-V: BABY) (OTCQB: BABYF) (FSE: 0YL) ("Different" or the "society”), the...